Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05094466 · ClinicalTrials.gov registry record · NA

Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families

A NA study of Obesity-Related Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
120
Enrollment target
1
Study location

NCT05094466: Active NA study of Obesity-Related Malignant Neoplasm, sponsored by M.D. Anderson Cancer Center.

NCT05094466 is a NA study of Obesity-Related Malignant Neoplasm that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 120 participants, below the 239-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05094466, a NA study of Obesity-Related Malignant Neoplasm, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

This clinical trial compares the effects of parent/caregiver-focused programs to family-focused programs in reducing obesity risk in racial ethnic minority families. Obesity tends to run in families, thus family-based interventions have been strongly recommended. Parent and family obesity programs may reduce obesity risk and ultimately reduce the risk of obesity-related cancer.

Interventions

  • OTHER Educational Intervention
  • BEHAVIORAL Behavioral Intervention
  • OTHER Counseling
  • PROCEDURE Discussion
  • OTHER Informational Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2019-07-16
Est. Completion 2027-02-02
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the registry record for NCT05094466 still lists

NCT05094466 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 239-participant average among 6 other Obesity-Related Malignant Neoplasm trials with a reported enrollment target (50% lower).

The record links to 1 condition, with Obesity-Related Malignant Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Educational Intervention is the first listed.

NCT05094466 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05094466 about?

NCT05094466 is a clinical study titled "Parent and Family Obesity Intervention in Reducing Obesity Risk in Racial Ethnic Minority Families". This clinical trial compares the effects of parent/caregiver-focused programs to family-focused programs in reducing obesity risk in racial ethnic minority families. Obesity tends to run in families, thus family-based interventions have been strongly recommended. Parent and family obesity programs m...

What is the current status of trial NCT05094466?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2019-07-16. Estimated completion is 2027-02-02.

What conditions does trial NCT05094466 study?

This clinical trial studies the following conditions: Obesity-Related Malignant Neoplasm.

What interventions are being tested in trial NCT05094466?

The interventions under investigation include: Educational Intervention (OTHER), Behavioral Intervention (BEHAVIORAL), Counseling (OTHER), Discussion (PROCEDURE), Informational Intervention (OTHER).

Who is sponsoring clinical trial NCT05094466?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05094466 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity-Related Malignant Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05094466, the US trial registry maintained by the National Library of Medicine. NCT05094466 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.